Skip to main content
. 2022 Aug 25;29(9):6137–6153. doi: 10.3390/curroncol29090482

Figure 2.

Figure 2

Efficacy of celecoxib-combined palliative therapy in different cancer types on overall survival (OS) (A) and progression-free survival (PFS) (B). HR: hazard ratio; CI: confidence interval [29,31,41,42,48,50,51,52,56,58,59,60,61,62,63].